CYCLIC PEPTIDE FROM NONOMURAEA SP., PROCESS FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MYCOBACTERIA RELATED DISEASE COMPRISING THE SAME

The present invention relates to a new anti-TB cyclic peptide from a nonomuraea species MJM5123, a process for producing the anti-TB peptide, and a pharmaceutical composition for treating and preventing a mycobacteria infection including the same. The composition of the present invention can be effe...

Full description

Saved in:
Bibliographic Details
Main Authors GAO WEI, LEE, SANG WOOK, SUH, JOO WON, KIM, JONG WOO, PARK, SANG JIN, FRIESEN BRENT, JIN YING YU, LEE, JI EAN, RODRIGUEZ BRASCO MARIA FLORENCIA, YOON, TAE MI, CHOI, JONG KEUN, LANKIN DAVID, CHO, SANG HYUN, JAKI BIRGIT, LEE, IN AE, MCALPINE JAMES, KIM, JIN YONG, FRANZBLAU SCOTT, PAULI GUIDO, NAPOLITANO JOSE
Format Patent
LanguageEnglish
Korean
Published 13.01.2014
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a new anti-TB cyclic peptide from a nonomuraea species MJM5123, a process for producing the anti-TB peptide, and a pharmaceutical composition for treating and preventing a mycobacteria infection including the same. The composition of the present invention can be effectively used as a TB medicine because the composition is very active against a replication/non-replication M. TB including an MDR and an XDR.
Bibliography:Application Number: KR20137030572